Whoop Secures $575M at $10.1B Valuation, Eyes IPO as Fitness Wearables Heat Up

Whoop just closed a $575 million Series G that catapults its valuation to $10.1 billion. That's nearly triple the $3.6 billion tag it carried in 2022. The round, announced March 31, 2026, becomes the largest venture deal of the year for any Massachusetts startup and instantly dwarfs the combined public-market caps of local peers like CarGurus, Tripadvisor, Rapid7, and Progress Software, according to the Boston Globe.

The raise eclipses the $200 million Series F that valued Whoop at $3.6 billion just four years ago. With more than $800 million now raised in total, Whoop has joined the rarefied club of private hardware-plus-subscription companies valued in the double-digit billions.

Collaborative Fund led the round, but the cap table reads like a geopolitical and celebrity mash-up. Sovereign wealth funds from Qatar and Singapore took large positions, while Cristiano Ronaldo, LeBron James, Rory McIlroy, and Patrick Mahomes all chipped in via personal vehicles. Mayo Clinic joined as a strategic investor, deepening a research partnership that has already produced peer-reviewed sleep and recovery studies.

The participation of superstar athletes isn't just marketing gloss. These investors wear the band 24/7 and supply anonymized performance data that Whoop uses to refine algorithms and demonstrate efficacy to both consumers and medical partners.

Revenue momentum explains the valuation leap. Whoop ended 2025 with 2.5 million paying members and bookings up 103 % year-over-year, Proactive Investors reports. The subscription model (starting at $30/month) locks users into a recurring revenue stream that Wall Street loves far more than one-off gadget sales.

Unlike Apple Watch or Fitbit, Whoop sells no hardware at retail. A free band arrives in exchange for a multi-month commitment, turning the device into a loss-leader for a high-margin data platform. That approach has pushed lifetime customer value well past $1,000 and gross margins north of 60 %, according to investor briefings cited by TechCrunch.

CEO Will Ahmed has stopped playing coy about an IPO. In a Bloomberg TV interview taped the morning of the raise, he said the company is "building the infrastructure you’d expect of a public company" and will "look at the public markets when the time is right." Translation: expect an S-1 filing within 12–18 months.

To get there, Whoop plans to expand headcount by 75 % across engineering, data science, and international sales, Yahoo Finance reports. The new cash will also bankroll a European headquarters in Dublin and deeper penetration into Asia-Pacific markets where fitness wearables are still under-penetrated.

The raise instantly tightens the screws on rivals like Oura, Garmin, and even Apple. Whoop can now pour hundreds of millions into R&D for next-gen sensors, clinical trials, and physician partnerships that smaller startups can’t match. Mayo Clinic’s participation signals an intensifying push into regulated medical devices, a space Apple has eyed but not yet conquered.

For investors, the deal validates the thesis that hardware-plus-subscription can scale to software-like margins. Expect VCs to pour fresh capital into second-tier recovery-ring startups hoping to become the next Whoop—or an attractive acquisition target once public-market liquidity arrives.

Watch for three near-term moves. First, Whoop will likely file confidential IPO paperwork this fall, setting up a public debut in Q2 2027. Second, expect at least one major healthcare partnership announcement—possibly a payor willing to subsidize memberships in exchange for reduced claims. Third, anticipate a sensor refresh that adds non-invasive glucose or blood-pressure monitoring, features that would leapfrog current wearables and justify premium pricing.

If the IPO window stays open, Whoop could debut with a market cap north of $12 billion, giving early employees and athlete-investors a liquidity event that turns sweat equity into actual equity. The company that started as a Harvard dorm-room project is about to become the first pure-play recovery-tech stock on public markets.